26197224|t|Neuroprotective effect of astaxanthin against glutamate-induced cytotoxicity in HT22 cells: Involvement of the Akt/GSK-3beta pathway.
26197224|a|Oxidative stress (OS) mediated the pathogenesis of Alzheimer's disease (AD). Astaxanthin (ATX) has been reported to exert antioxidant activities as well as neuroprotective effects in vivo and in vitro. But it is still unknown whether the Akt/glycogen synthase kinase-3beta (GSK-3beta) signaling mediated the neuroprotective effect of ATX in HT22 cells. Flow cytometric analysis was used to evaluate reactive oxygen species (ROS) generation. Caspase and PARP activity was measured. The expressions of heme oxygenase-1 (HO-1), nuclear factor-E2-related factor 2 (Nrf2), Bcl-2, Bax, apoptosis-inducing factor (AIF), cytochrome-c (Cyto-c), p-Akt and p-GSK-3beta were evaluated to elucidate the underlying mechanism. Our results showed that ATX significantly attenuated glutamate-induced cell viability loss and lactate dehydrogenase (LDH) release, decreased the expression of caspase-3/8/9 activity and cleaved PARP, and suppressed the intracellular accumulation of ROS in HT22 cells after exposure to glutamate. ATX also increased the mitochondrial expression of AIF, Cyto-c as well as Bax while decreased Bcl-2. Moreover, ATX also induced the HO-1 expression in a dose and time-dependent manner, increased the antioxidant-responsive element (ARE) activity and nuclear Nrf2 expression. Furthermore, treatment with ATX restored the p-Akt and p-GSK-3beta (Ser9) as well as HO-1 expression reduced by glutamate. This protective effect was partially blocked by the inhibitors lithium chloride treatment in HT22, indicating the involvement of Akt/GSK-3beta inactivation during the neuroprotective effect of ATX. Our results provide the first evidence that ATX can protect glutamate-induced cytotoxicity in HT22 via attenuating caspase activation and mitochondrial dysfunction and modulating the Akt/GSK-3beta signaling, indicating ATX may be useful for the treatment of neurodegenerative disorders such as AD. 
26197224	26	37	astaxanthin	Chemical	MESH:C005948
26197224	46	55	glutamate	Chemical	MESH:D018698
26197224	64	76	cytotoxicity	Disease	MESH:D064420
26197224	80	84	HT22	CellLine	CVCL:0321
26197224	111	114	Akt	Gene	11651
26197224	115	124	GSK-3beta	Gene	56637
26197224	185	204	Alzheimer's disease	Disease	MESH:D000544
26197224	206	208	AD	Disease	MESH:D000544
26197224	211	222	Astaxanthin	Chemical	MESH:C005948
26197224	224	227	ATX	Chemical	MESH:C005948
26197224	372	375	Akt	Gene	11651
26197224	376	406	glycogen synthase kinase-3beta	Gene	56637
26197224	408	417	GSK-3beta	Gene	56637
26197224	468	471	ATX	Chemical	MESH:C005948
26197224	475	479	HT22	CellLine	CVCL:0321
26197224	533	556	reactive oxygen species	Chemical	MESH:D017382
26197224	558	561	ROS	Chemical	MESH:D017382
26197224	587	591	PARP	Gene	11545
26197224	634	650	heme oxygenase-1	Gene	15368
26197224	652	656	HO-1	Gene	15368
26197224	659	693	nuclear factor-E2-related factor 2	Gene	18024
26197224	695	699	Nrf2	Gene	18024
26197224	702	707	Bcl-2	Gene	12043
26197224	709	712	Bax	Gene	12028
26197224	714	739	apoptosis-inducing factor	Gene	26926
26197224	741	744	AIF	Gene	26926
26197224	772	775	Akt	Gene	11651
26197224	782	791	GSK-3beta	Gene	56637
26197224	870	873	ATX	Chemical	MESH:C005948
26197224	899	908	glutamate	Chemical	MESH:D018698
26197224	1041	1045	PARP	Gene	11545
26197224	1096	1099	ROS	Chemical	MESH:D017382
26197224	1103	1107	HT22	CellLine	CVCL:0321
26197224	1132	1141	glutamate	Chemical	MESH:D018698
26197224	1143	1146	ATX	Chemical	MESH:C005948
26197224	1194	1197	AIF	Gene	26926
26197224	1217	1220	Bax	Gene	12028
26197224	1237	1242	Bcl-2	Gene	12043
26197224	1254	1257	ATX	Chemical	MESH:C005948
26197224	1275	1279	HO-1	Gene	15368
26197224	1400	1404	Nrf2	Gene	18024
26197224	1445	1448	ATX	Chemical	MESH:C005948
26197224	1464	1467	Akt	Gene	11651
26197224	1474	1483	GSK-3beta	Gene	56637
26197224	1502	1506	HO-1	Gene	15368
26197224	1529	1538	glutamate	Chemical	MESH:D018698
26197224	1603	1619	lithium chloride	Chemical	MESH:D018021
26197224	1633	1637	HT22	CellLine	CVCL:0321
26197224	1669	1672	Akt	Gene	11651
26197224	1673	1682	GSK-3beta	Gene	56637
26197224	1733	1736	ATX	Chemical	MESH:C005948
26197224	1782	1785	ATX	Chemical	MESH:C005948
26197224	1798	1807	glutamate	Chemical	MESH:D018698
26197224	1816	1828	cytotoxicity	Disease	MESH:D064420
26197224	1832	1836	HT22	CellLine	CVCL:0321
26197224	1876	1901	mitochondrial dysfunction	Disease	MESH:D028361
26197224	1921	1924	Akt	Gene	11651
26197224	1925	1934	GSK-3beta	Gene	56637
26197224	1957	1960	ATX	Chemical	MESH:C005948
26197224	1996	2023	neurodegenerative disorders	Disease	MESH:D019636
26197224	2032	2034	AD	Disease	MESH:D000544
26197224	Positive_Correlation	MESH:C005948	15368
26197224	Negative_Correlation	MESH:D018021	56637
26197224	Positive_Correlation	MESH:C005948	26926
26197224	Negative_Correlation	MESH:C005948	MESH:D018698
26197224	Association	MESH:D018698	MESH:D028361
26197224	Association	MESH:C005948	11651
26197224	Positive_Correlation	MESH:C005948	18024
26197224	Negative_Correlation	MESH:D018698	15368
26197224	Negative_Correlation	MESH:C005948	12043
26197224	Negative_Correlation	MESH:C005948	MESH:D064420
26197224	Negative_Correlation	MESH:C005948	11545
26197224	Association	MESH:D064420	56637
26197224	Negative_Correlation	MESH:C005948	MESH:D028361
26197224	Association	MESH:D018698	11651
26197224	Association	11651	56637
26197224	Association	MESH:C005948	56637
26197224	Negative_Correlation	MESH:D018698	56637
26197224	Negative_Correlation	MESH:C005948	MESH:D017382
26197224	Positive_Correlation	MESH:D018698	MESH:D064420
26197224	Positive_Correlation	MESH:C005948	12028
26197224	Association	MESH:D064420	11651

